Maine Writer

Its about people and issues I care about.

My Photo
Name:
Location: Topsham, MAINE, United States

My blogs are dedicated to the issues I care about. Thank you to all who take the time to read something I've written.

Friday, August 03, 2018

Donald Trump unhinges the definition of "unhinged"!

Echo opinion published in the West Virginia Gazette Mail newspaper in Charleston WV, originally published in the Washington Post written by Ruth Marcus. 

Trump unhinged

Future generations will feel only contempt for the right wing extremist rantings by Donald Trump 

Donald Trump’s outrageous tweets are testing, once again, our capacity for outrage. 

They are not harmless venting. Rather, they pose a threat to the rule of law.
Unbelievably, Trump launched yet another unfounded (unhinged!) attack against special counsel Robert S. Mueller III, as being “totally conflicted.” Moreover, Trump slandered the prosecutors (“17 Angry Democrats”) doing Mueller’s “dirty work” as a “disgrace to USA.”

And, most alarmingly, Trump called on his attorney Sessions general to “stop this Rigged Witch Hunt right now, before it continues to stain our country any further.” A measure of how alarming was the scrambling by Trump’s team of enablers to explain that the president was not, in fact, ordering Attorney General Jeff Sessions to kill the investigation. Rather, in this soft-core retelling, Trump was merely expressing his opinion about what should happen — as if that is much better, when the opinionizer is the president (ugh!).

Note to the president: “Our country” is doing just fine with the Mueller probe. Actually, the United States is benefiting from it. The country being stained by the investigation is the one that tried to interfere with our election on Trump’s behalf. 

One of the indictments that Mueller has produced alleged that Russian individuals and companies engaged in a sophisticated social-media campaign to help swing the election to Trump. Another accused Russian military intelligence agents of hacking into the emails of Democratic campaigns and operatives.

Someone needs to ask — or would ask, if the president ever took more than a few shouted questions from a few favored reporters — how bringing such cases is a “stain” on the United States. Rather, it is a defense of the country and its electoral system, which is more than we have seen from the Trump administration.

Leave aside the matter of whether Trump’s attacks on the Russia “hoax” represent potential evidence in an obstruction case against him. That is worth considering, but the focus on his tweets as obstruction in plain sight has obscured the even more concerning fact that the tweets offer incontrovertible evidence of a president who cares nothing about the well-being of his country and the integrity of its elections.

A president who cared about this would be insisting that Mueller get to the bottom of what happened, not doing his best to undermine the special counsel’s legitimacy. He would not be ordering, or even suggesting, that his attorney general — his properly recused attorney general — shut it all down.

The same is true of the just-begun trial of Trump’s former campaign chairman, Paul Manafort, who is accused of bank and tax fraud charges involving laundering more than $30 million in income. A responsible president would allow the Manafort case to proceed without comment, for fear of tainting it, but would privately seethe over the alleged misconduct of a man who once sat at the helm of his campaign.

Not Trump. He managed, simultaneously, to vouch for Manafort’s political bona fides (“worked for Ronald Reagan, Bob Dole and many other highly prominent and respected political leaders” ~ (Hello? Those people are not on trail!); distance himself from Manafort (“he worked for me for a very short time”); and portray himself as the victim of government malfeasance (“Why didn’t government tell me that he was under investigation”).

Then came even worse — a tweet suggesting that, far from wanting to see Manafort brought to justice, we should somehow feel pity for him. “Looking back on history, who was treated worse, Alfonse Capone, legendary mob boss, killer and ‘Public Enemy Number One,’ or Paul Manafort, political operative & Reagan/Dole darling, now serving solitary confinement — although convicted of nothing?” Trump wrote, misspelling the first name (Alphonse) of the notorious Chicago mobster.

How nice that Trump, channeling his previously hidden civil libertarian, cares so much about due process for those not convicted of crimes. Maybe there are some detained families and separated children he could worry about instead of Manafort? Recall, Manafort was jailed before trial only after prosecutors accused him of trying to tamper with the witnesses in the case against him. A federal judge agreed, telling Manafort, “You’ve abused the trust placed in you six months ago.”

In fact, the Capone-Manafort comparison doesn’t exactly benefit Manafort. Capone was convicted of failing to pay taxes on his illicit income, a case federal prosecutors made by showing evidence of Capone’s copious spending. 

Manafort is similarly accused of filing false tax returns — and as the indictment put it, “used his hidden overseas wealth to enjoy a lavish lifestyle in the United States, without paying taxes on that income.”

Future generations looking back on history, to use Trump’s phrase, are not likely to feel pity for either Capone or Manafort. Or anything but contempt for Trump and the way he besmirched his office daily.

Ruth Marcus is deputy editorial page editor and columnist for The Washington Post.

Postscript ~ Where are the Republicans?

Labels: , , , ,

Sunday, April 15, 2018

Children ~ when pharmacy management cut benefits: echo from West Virginia

"Big pharma" is an euphemism for "Big profits", at the expense of quality patient care.


Diabetes insulin
In other words, when pharmacy management programs cut particular drugs our of their formulary lists (meaning the medicine is not covered), the result is that patients must either pay the price gouging costs or suffer the health  consequences. In the situations where children with diabetes cannot obtain their pharmacy needs through their insurance plans, either via Medicaid or private coverage, the problem can lead to preventable chronic health diseases or even early death.  Although this "echo", editorial published in the West Virginia Gazette Mail newspaper and blogged by me, the opinion describes the situation in the Mountain State and the price gouging, in fact, is also going on in other states.

Children pay when insurers cut diabetes coverage

Children with diabetes face a lifetime of challenges. 

However, if insurers continue to exclude more and more diabetes-related medications and supplies from coverage, those children and their families could be saddled with a lifetime of exorbitant out-of-pocket costs as well.

West Virginia’s rate of diabetes has steadily increased. More than 15 percent of West Virginians have been diagnosed with the disease, the highest rate among all states.

The growing incidence of diabetes may be one reason pharmacy benefit managers (PBMs) — the private companies health plans hire to oversee their prescription drug benefits — consistently exclude diabetes-related medications and supplies from coverage, more than any other treatment category. That’s according to a study by the Doctor-Patient Rights Project, which analyzed the increasing use of formulary exclusion lists, the catalogs PBMs issue to lay out the medicines they will 
no longer cover.
In the last four years, the number of diabetes-related medications or supplies excluded from coverage by the nation’s two largest PBMs (CVS and Express Scripts) has increased by almost 80 percent, the only treatment category where the PBMs consistently increased the number of excluded medicines every year. Diabetes-related treatments now account for one out of every five medicines excluded from coverage by these PBMs.

PBMs use formulary exclusion lists to compel patients to choose less-expensive treatment, falsely assuming that every diabetes patient will respond the same way to every treatment. They are a form of forced, nonmedical switching designed to save the insurer from having to pay for treatments chosen by the patient and physician.

The Doctor-Patient Rights Project found that many patients asked to switch to a new medication choose to pay out-of-pocket for the treatment their doctor originally prescribed, rather than switch to the insurer’s preferred drug. In effect, formulary exclusions simply transfer more of the cost of prescribed treatments to patients and their families.

Studies show that patients forced to shoulder more of the expense of their medications are more likely to try to make the prescriptions for their original medication last longer by splitting pills or skipping doses of insulin.

People with diabetes who do not experience immediate symptoms from not following proper treatment protocols may wrongly conclude that the medicine remains just as effective or that they need less of it. This is especially true of low-income and minority patients, who are already more likely to develop diabetes and to experience diabetes-related organ failure.


All parents want the best for their child, including the medicine the doctor believes will best care for their child’s diabetes. 


Insurers that refuse to cover certain prescribed diabetes treatments, thinking that parents will simply switch to the insurer’s cheaper alternative, may be gravely mistaken. Forced nonmedical switching may simply increase out-of-pocket expenses for parents, and, as a result, increase the lifetime treatment costs for their children with diabetes.

Forced nonmedical switching may even backfire as a cost-saving strategy for insurers. When patients fail to adhere to proper medication protocols, they make treatment less and less effective.

Reduced adherence, in fact, accounts for up to 10 percent of hospitalizations, 25 percent of nursing home admissions and as many as 125,000 premature deaths annually, according to a study in the Journal of Managed Care & Specialty Pharmacy. 

As a result, it contributes an extra $100 billion to $289 billion in medical expenses each year, at least some of which fall to insurers to pay.

Insurers that target diabetes-related medications and supplies for exclusion are being short-sighted.

When they fully cover prescribed treatments, insurers permit parents to start their children on the most effective medications and to use them appropriately. As a result, they experience improved clinical outcomes and fewer lifetime medical costs. The money saved by letting doctors drive treatment decisions more than compensates for the higher pharmaceutical costs.

This opinion was authored by Jeff Hitchcock, the founder and president of Children with Diabetes, one of the most established and well-trafficked online diabetes communities, and a member of the Doctor-Patient Rights Project. 

Stewart Perry is the past national chairman of the board of the American Diabetes Association, and the parent of a child with diabetes.

Labels: , ,